Waters, Bruker Report Double-Digit Mass Spec Revenue Growth in Q2

A Waters' official said the company's mass spec business was its "strongest performer across the line," while Bruker touted healthy growth in revenues and new orders in life sciences mass spec.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.